Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
Prolactin and Risk of Epithelial Ovarian Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Hathaway CA, Rice MS, Townsend MK, Hankinson SE, Arslan AA, Buring JE, Hallmans G, Idahl A, Kubzansky LD, Lee IM, Lundin EA, Sluss PM, Zeleniuch-Jacquotte A, Tworoger SS.
PMID: 34244157
Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1652-1659. doi: 10.1158/1055-9965.EPI-21-0139. Epub 2021 Jul 08.

BACKGROUND: Prolactin is synthesized in the ovaries and may play a role in ovarian cancer etiology. One prior prospective study observed a suggestive positive association between prolactin levels and risk of ovarian cancer.METHODS: We conducted a pooled case-control study...

Cite
Hathaway CA, Rice MS, Townsend MK, et al. Prolactin and Risk of Epithelial Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2021;30(9):1652-1659doi: 10.1158/1055-9965.EPI-21-0139.
Hathaway, C. A., Rice, M. S., Townsend, M. K., Hankinson, S. E., Arslan, A. A., Buring, J. E., Hallmans, G., Idahl, A., Kubzansky, L. D., Lee, I. M., Lundin, E. A., Sluss, P. M., Zeleniuch-Jacquotte, A., & Tworoger, S. S. (2021). Prolactin and Risk of Epithelial Ovarian Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(9), 1652-1659. https://doi.org/10.1158/1055-9965.EPI-21-0139
Hathaway, Cassandra A, et al. "Prolactin and Risk of Epithelial Ovarian Cancer." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 30,9 (2021): 1652-1659. doi: https://doi.org/10.1158/1055-9965.EPI-21-0139
Hathaway CA, Rice MS, Townsend MK, Hankinson SE, Arslan AA, Buring JE, Hallmans G, Idahl A, Kubzansky LD, Lee IM, Lundin EA, Sluss PM, Zeleniuch-Jacquotte A, Tworoger SS. Prolactin and Risk of Epithelial Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1652-1659. doi: 10.1158/1055-9965.EPI-21-0139. Epub 2021 Jul 08. PMID: 34244157; PMCID: PMC8419083.
Copy Download .nbib Format: NLM
Association of Step Volume and Intensity With All-Cause Mortality in Older Women.

JAMA internal medicine

Lee IM, Shiroma EJ, Kamada M, Bassett DR, Matthews CE, Buring JE.
PMID: 31141585
JAMA Intern Med. 2019 Aug 01;179(8):1105-1112. doi: 10.1001/jamainternmed.2019.0899.

IMPORTANCE: A goal of 10 000 steps/d is commonly believed by the public to be necessary for health, but this number has limited scientific basis. Additionally, it is unknown whether greater stepping intensity is associated with health benefits, independent...

Cite
Lee IM, Shiroma EJ, Kamada M, et al. Association of Step Volume and Intensity With All-Cause Mortality in Older Women. JAMA Intern Med. 2019;179(8):1105-1112doi: 10.1001/jamainternmed.2019.0899.
Lee, I. M., Shiroma, E. J., Kamada, M., Bassett, D. R., Matthews, C. E., & Buring, J. E. (2019). Association of Step Volume and Intensity With All-Cause Mortality in Older Women. JAMA internal medicine, 179(8), 1105-1112. https://doi.org/10.1001/jamainternmed.2019.0899
Lee, I-Min, et al. "Association of Step Volume and Intensity With All-Cause Mortality in Older Women." JAMA internal medicine vol. 179,8 (2019): 1105-1112. doi: https://doi.org/10.1001/jamainternmed.2019.0899
Lee IM, Shiroma EJ, Kamada M, Bassett DR, Matthews CE, Buring JE. Association of Step Volume and Intensity With All-Cause Mortality in Older Women. JAMA Intern Med. 2019 Aug 01;179(8):1105-1112. doi: 10.1001/jamainternmed.2019.0899. PMID: 31141585; PMCID: PMC6547157.
Copy Download .nbib Format: NLM
Prolactin and Risk of Epithelial Ovarian Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Hathaway CA, Rice MS, Townsend MK, Hankinson SE, Arslan AA, Buring JE, Hallmans G, Idahl A, Kubzansky LD, Lee IM, Lundin EA, Sluss PM, Zeleniuch-Jacquotte A, Tworoger SS.
PMID: 34244157
Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1652-1659. doi: 10.1158/1055-9965.EPI-21-0139. Epub 2021 Jul 08.

BACKGROUND: Prolactin is synthesized in the ovaries and may play a role in ovarian cancer etiology. One prior prospective study observed a suggestive positive association between prolactin levels and risk of ovarian cancer.METHODS: We conducted a pooled case-control study...

Cite
Hathaway CA, Rice MS, Townsend MK, et al. Prolactin and Risk of Epithelial Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2021;30(9):1652-1659doi: 10.1158/1055-9965.EPI-21-0139.
Hathaway, C. A., Rice, M. S., Townsend, M. K., Hankinson, S. E., Arslan, A. A., Buring, J. E., Hallmans, G., Idahl, A., Kubzansky, L. D., Lee, I. M., Lundin, E. A., Sluss, P. M., Zeleniuch-Jacquotte, A., & Tworoger, S. S. (2021). Prolactin and Risk of Epithelial Ovarian Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(9), 1652-1659. https://doi.org/10.1158/1055-9965.EPI-21-0139
Hathaway, Cassandra A, et al. "Prolactin and Risk of Epithelial Ovarian Cancer." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 30,9 (2021): 1652-1659. doi: https://doi.org/10.1158/1055-9965.EPI-21-0139
Hathaway CA, Rice MS, Townsend MK, Hankinson SE, Arslan AA, Buring JE, Hallmans G, Idahl A, Kubzansky LD, Lee IM, Lundin EA, Sluss PM, Zeleniuch-Jacquotte A, Tworoger SS. Prolactin and Risk of Epithelial Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1652-1659. doi: 10.1158/1055-9965.EPI-21-0139. Epub 2021 Jul 08. PMID: 34244157; PMCID: PMC8419083.
Copy Download .nbib Format: NLM
Cohort profile: the Women's Health Accelerometry Collaboration.

BMJ open

Evenson KR, Bellettiere J, Cuthbertson CC, Di C, Dushkes R, Howard AG, Parada H, Schumacher BT, Shiroma EJ, Wang G, Lee IM, LaCroix AZ.
PMID: 34845070
BMJ Open. 2021 Nov 29;11(11):e052038. doi: 10.1136/bmjopen-2021-052038.

PURPOSE: This paper describes the Women's Health Accelerometry Collaboration, a consortium of two prospective cohort studies of women age 62 years or older, harmonised to explore the association of accelerometer-assessed physical activity and sedentary behaviour with cancer incidence and...

Cite
Evenson KR, Bellettiere J, Cuthbertson CC, et al. Cohort profile: the Women's Health Accelerometry Collaboration. BMJ Open. 2021;11(11):e052038doi: 10.1136/bmjopen-2021-052038.
Evenson, K. R., Bellettiere, J., Cuthbertson, C. C., Di, C., Dushkes, R., Howard, A. G., Parada, H., Schumacher, B. T., Shiroma, E. J., Wang, G., Lee, I. M., & LaCroix, A. Z. (2021). Cohort profile: the Women's Health Accelerometry Collaboration. BMJ open, 11(11), e052038. https://doi.org/10.1136/bmjopen-2021-052038
Evenson, Kelly R, et al. "Cohort profile: the Women's Health Accelerometry Collaboration." BMJ open vol. 11,11 (2021): e052038. doi: https://doi.org/10.1136/bmjopen-2021-052038
Evenson KR, Bellettiere J, Cuthbertson CC, Di C, Dushkes R, Howard AG, Parada H, Schumacher BT, Shiroma EJ, Wang G, Lee IM, LaCroix AZ. Cohort profile: the Women's Health Accelerometry Collaboration. BMJ Open. 2021 Nov 29;11(11):e052038. doi: 10.1136/bmjopen-2021-052038. PMID: 34845070; PMCID: PMC8633996.
Copy Download .nbib Format: NLM
Using Devices to Assess Physical Activity and Sedentary Behavior in a Large Cohort Study, the Women's Health Study.

Journal for the measurement of physical behaviour

Lee IM, Shiroma EJ, Evenson KR, Kamada M, LaCroix AZ, Buring JE.
PMID: 30666321
J Meas Phys Behav. 2018 Jun;1(2):60-69. doi: 10.1123/jmpb.2018-0005.

In recent years, it has become feasible to use devices for assessing physical activity and sedentary behavior among large numbers of participants in epidemiologic studies, allowing for more precise assessments of these behaviors and quantification of their associations with...

Cite
Lee IM, Shiroma EJ, Evenson KR, et al. Using Devices to Assess Physical Activity and Sedentary Behavior in a Large Cohort Study, the Women's Health Study. J Meas Phys Behav. 2018;1(2):60-69doi: 10.1123/jmpb.2018-0005.
Lee, I. M., Shiroma, E. J., Evenson, K. R., Kamada, M., LaCroix, A. Z., & Buring, J. E. (2018). Using Devices to Assess Physical Activity and Sedentary Behavior in a Large Cohort Study, the Women's Health Study. Journal for the measurement of physical behaviour, 1(2), 60-69. https://doi.org/10.1123/jmpb.2018-0005
Lee, I-Min, et al. "Using Devices to Assess Physical Activity and Sedentary Behavior in a Large Cohort Study, the Women's Health Study." Journal for the measurement of physical behaviour vol. 1,2 (2018): 60-69. doi: https://doi.org/10.1123/jmpb.2018-0005
Lee IM, Shiroma EJ, Evenson KR, Kamada M, LaCroix AZ, Buring JE. Using Devices to Assess Physical Activity and Sedentary Behavior in a Large Cohort Study, the Women's Health Study. J Meas Phys Behav. 2018 Jun;1(2):60-69. doi: 10.1123/jmpb.2018-0005. PMID: 30666321; PMCID: PMC6338453.
Copy Download .nbib Format: NLM
Cohort profile: the Women's Health Accelerometry Collaboration.

BMJ open

Evenson KR, Bellettiere J, Cuthbertson CC, Di C, Dushkes R, Howard AG, Parada H, Schumacher BT, Shiroma EJ, Wang G, Lee IM, LaCroix AZ.
PMID: 34845070
BMJ Open. 2021 Nov 29;11(11):e052038. doi: 10.1136/bmjopen-2021-052038.

PURPOSE: This paper describes the Women's Health Accelerometry Collaboration, a consortium of two prospective cohort studies of women age 62 years or older, harmonised to explore the association of accelerometer-assessed physical activity and sedentary behaviour with cancer incidence and...

Cite
Evenson KR, Bellettiere J, Cuthbertson CC, et al. Cohort profile: the Women's Health Accelerometry Collaboration. BMJ Open. 2021;11(11):e052038doi: 10.1136/bmjopen-2021-052038.
Evenson, K. R., Bellettiere, J., Cuthbertson, C. C., Di, C., Dushkes, R., Howard, A. G., Parada, H., Schumacher, B. T., Shiroma, E. J., Wang, G., Lee, I. M., & LaCroix, A. Z. (2021). Cohort profile: the Women's Health Accelerometry Collaboration. BMJ open, 11(11), e052038. https://doi.org/10.1136/bmjopen-2021-052038
Evenson, Kelly R, et al. "Cohort profile: the Women's Health Accelerometry Collaboration." BMJ open vol. 11,11 (2021): e052038. doi: https://doi.org/10.1136/bmjopen-2021-052038
Evenson KR, Bellettiere J, Cuthbertson CC, Di C, Dushkes R, Howard AG, Parada H, Schumacher BT, Shiroma EJ, Wang G, Lee IM, LaCroix AZ. Cohort profile: the Women's Health Accelerometry Collaboration. BMJ Open. 2021 Nov 29;11(11):e052038. doi: 10.1136/bmjopen-2021-052038. PMID: 34845070; PMCID: PMC8633996.
Copy Download .nbib Format: NLM
Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study.

Journal of clinical lipidology

Imran TF, Kim E, Buring JE, Lee IM, Gaziano JM, Djousse L.
PMID: 33500188
J Clin Lipidol. 2021 Mar-Apr;15(2):266-274. doi: 10.1016/j.jacl.2021.01.001. Epub 2021 Jan 07.

BACKGROUND: The link between nut consumption and cardiovascular (CV) mortality remains unclear.OBJECTIVE: to examine whether nut consumption is associated with CV mortality and estimate the proportion of reduced risk of CV mortality explained by intermediate factors.METHODS: We studied 39,167...

Cite
Imran TF, Kim E, Buring JE, et al. Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study. J Clin Lipidol. 2021;15(2):266-274doi: 10.1016/j.jacl.2021.01.001.
Imran, T. F., Kim, E., Buring, J. E., Lee, I. M., Gaziano, J. M., & Djousse, L. (2021). Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study. Journal of clinical lipidology, 15(2), 266-274. https://doi.org/10.1016/j.jacl.2021.01.001
Imran, Tasnim F, et al. "Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study." Journal of clinical lipidology vol. 15,2 (2021): 266-274. doi: https://doi.org/10.1016/j.jacl.2021.01.001
Imran TF, Kim E, Buring JE, Lee IM, Gaziano JM, Djousse L. Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study. J Clin Lipidol. 2021 Mar-Apr;15(2):266-274. doi: 10.1016/j.jacl.2021.01.001. Epub 2021 Jan 07. PMID: 33500188; PMCID: PMC8666004.
Copy Download .nbib Format: NLM
Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study.

Journal of clinical lipidology

Imran TF, Kim E, Buring JE, Lee IM, Gaziano JM, Djousse L.
PMID: 33500188
J Clin Lipidol. 2021 Mar-Apr;15(2):266-274. doi: 10.1016/j.jacl.2021.01.001. Epub 2021 Jan 07.

BACKGROUND: The link between nut consumption and cardiovascular (CV) mortality remains unclear.OBJECTIVE: to examine whether nut consumption is associated with CV mortality and estimate the proportion of reduced risk of CV mortality explained by intermediate factors.METHODS: We studied 39,167...

Cite
Imran TF, Kim E, Buring JE, et al. Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study. J Clin Lipidol. 2021;15(2):266-274doi: 10.1016/j.jacl.2021.01.001.
Imran, T. F., Kim, E., Buring, J. E., Lee, I. M., Gaziano, J. M., & Djousse, L. (2021). Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study. Journal of clinical lipidology, 15(2), 266-274. https://doi.org/10.1016/j.jacl.2021.01.001
Imran, Tasnim F, et al. "Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study." Journal of clinical lipidology vol. 15,2 (2021): 266-274. doi: https://doi.org/10.1016/j.jacl.2021.01.001
Imran TF, Kim E, Buring JE, Lee IM, Gaziano JM, Djousse L. Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study. J Clin Lipidol. 2021 Mar-Apr;15(2):266-274. doi: 10.1016/j.jacl.2021.01.001. Epub 2021 Jan 07. PMID: 33500188; PMCID: PMC8666004.
Copy Download .nbib Format: NLM
Cohort profile: the Women's Health Accelerometry Collaboration.

BMJ open

Evenson KR, Bellettiere J, Cuthbertson CC, Di C, Dushkes R, Howard AG, Parada H, Schumacher BT, Shiroma EJ, Wang G, Lee IM, LaCroix AZ.
PMID: 34845070
BMJ Open. 2021 Nov 29;11(11):e052038. doi: 10.1136/bmjopen-2021-052038.

PURPOSE: This paper describes the Women's Health Accelerometry Collaboration, a consortium of two prospective cohort studies of women age 62 years or older, harmonised to explore the association of accelerometer-assessed physical activity and sedentary behaviour with cancer incidence and...

Cite
Evenson KR, Bellettiere J, Cuthbertson CC, et al. Cohort profile: the Women's Health Accelerometry Collaboration. BMJ Open. 2021;11(11):e052038doi: 10.1136/bmjopen-2021-052038.
Evenson, K. R., Bellettiere, J., Cuthbertson, C. C., Di, C., Dushkes, R., Howard, A. G., Parada, H., Schumacher, B. T., Shiroma, E. J., Wang, G., Lee, I. M., & LaCroix, A. Z. (2021). Cohort profile: the Women's Health Accelerometry Collaboration. BMJ open, 11(11), e052038. https://doi.org/10.1136/bmjopen-2021-052038
Evenson, Kelly R, et al. "Cohort profile: the Women's Health Accelerometry Collaboration." BMJ open vol. 11,11 (2021): e052038. doi: https://doi.org/10.1136/bmjopen-2021-052038
Evenson KR, Bellettiere J, Cuthbertson CC, Di C, Dushkes R, Howard AG, Parada H, Schumacher BT, Shiroma EJ, Wang G, Lee IM, LaCroix AZ. Cohort profile: the Women's Health Accelerometry Collaboration. BMJ Open. 2021 Nov 29;11(11):e052038. doi: 10.1136/bmjopen-2021-052038. PMID: 34845070; PMCID: PMC8633996.
Copy Download .nbib Format: NLM
Showing 1 to 9 of 9 entries